PAYVANDI, FLORA
PAYVANDI, FLORA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Challenges and considerations of genetic testing in von Willebrand disease
2025 O. Seidizadeh, L. Baronciani, F. Peyvandi
Gene therapy in hemophilia: the dawn of a new era
2025 R. Gualtierotti, A. Giachi, N. Bitto, V. La Mura, F. Peyvandi
Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry
2025 K. Fischer, R. Lassila, F. Peyvandi, A. Gatt, S.C. Gouw, R. Hollingsworth, T. Lambert, R. Kaczmarek, D. Carbonero, M. Makris
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study
2024 P. Agosti, A. Kouraki, T. Dionisi, G. Addolorato, L. D'Innocenzo, S. Sorrentino, F. De Maio, E. De Candia, A. Blanco-Miguez, D. Bazzani, A. Bonadiman, G. Tonidandel, M. Bolzan, F. Gianniello, S.M. Passamonti, M. Abbattista, A.M. Valdes, P. Bucciarelli, F. Peyvandi, C. Menni
Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defects
2024 A. Lecchi, S. La Marca, L. Padovan, M. Boscarino, F. Peyvandi, A. Tripodi
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results
2024 C. Hermans, L.A. Valentino, C.D. Thornburg, C. Unzu, M.A. Kay, F. Peyvandi, P. Smith, W. Miesbach, W. Mckeown, G.F. Pierce, K. Khair, S.W. Pipe, K. Starcevic, M. Pillai, M. Jones, M. Chiao, I. Antonino, C. Kessler
Gender equity in hemophilia: need for healthcare, familial, and societal advocacy
2024 R. Gualtierotti, I. Garagiola, M. Mortarino, S. Spena, O. Romero-Lux, F. Peyvandi
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review
2024 A.C. Giuffrida, S.M. Siboni, L. Baronciani, G. Poli, G. Gandini, F. Peyvandi
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis
2024 A. Tripodi, M. Primignani, R. D'Ambrosio, G. Tosetti, V. La Mura, P. Lampertico, F. Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation
2024 A. Tripodi, M. Capecchi, E. Scalambrino, M. Clerici, B. Scimeca, P. Agosti, P. Bucciarelli, F. Peyvandi
Gene therapy for people with Haemophilia B: a proposed care delivery model in Italy
2024 G. Castaman, G. Di Minno, P. Simioni, A.C. Molinari, S. Siragusa, E. Baldacci, V. La Mura, A. Lupi, E.F. Grazzi, F. Peyvandi
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF
2024 O. Seidizadeh, A. Ciavarella, L. Baronciani, F. Boggio, F. Ballardini, G. Cozzi, P. Colpani, M.T. Pagliari, C. Novembrino, S.M. Siboni, F. Peyvandi
Rare inherited coagulation disorders: no longer orphan and neglected
2024 S. Mohsenian, P.M. Mannucci, M. Menegatti, F. Peyvandi
Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List
2024 G.F. Pierce, B. O'Mahony, R. Kaczmarek, M.W. Skinner, M. Makris, F. Peyvandi, A. Srivastava, C. Hermans, M. Crato, A. Dunn, E. Gouider, J. Mahlangu, D. Page, S.W. Pipe, M. Recht, T. Sannie, N. Schaefer, U. Schlenkrich, C. Garrido
The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia
2024 V. LA MURA, M. Colombo, G.R. Foster, P. Angeli, W. Miesbach, R. Klamroth, G.F. Pierce, B. O'Mahony, M.Y. Lim, V. HERNANDEZ-GEA, M. Makris, F. Peyvandi
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes
2024 J.W. Jacobs, C.G. Stanek, G.S. Booth, A. Symeonidis, A.W. Shih, E.S. Allen, E. Gavriilaki, B.J. Grossman, K. Pavenski, A. Moorehead, F. Peyvandi, P. Agosti, I. Mancini, L.D. Stephens, J.S. Raval, M.E. Mingot‐castellano, E.P. Crowe, L. Daou, M. Pai, D.M. Arnold, M.B. Marques, R. Henrie, T.W. Smith, G. Sreenivasan, R.C. Siniard, L.R. Wallace, C. Yamada, M.A. Duque, Y. Wu, T.J. Harrington, D.M. Byrnes, A. Bitsani, A.K. Davis, D.H. Robinson, Q. Eichbaum, C.A. Figueroa Villalba, J.E. Juskewitch, G. Kaiafa, E. Kapsali, E. Klapper, I. Perez‐alvarez, M.S. Klein, N. Kotsiou, C. Lalayanni, E. Mandala, F. Aldarweesh, R. Alkhateb, L. Fortuny, Z. Mellios, A. Papalexandri, M.G. Parsons, A.J. Schlueter, C.A. Tormey, C. Wellard, E.M. Wood, S. Jia, A.P. Wheeler, A.A. Powers, C.B. Webb, S.G. Yates, R. Bouzid, P. Coppo, E.M. Bloch, B.D. Adkins
von Willebrand disease
2024 O. Seidizadeh, J.C.J. Eikenboom, C.V. Denis, V.H. Flood, P. James, P.J. Lenting, L. Baronciani, J.S. O'Donnell, D. Lillicrap, F. Peyvandi
Ultrasound evaluation of hemophilic arthropathy: a proposal of definitions in a changing landscape
2024 R. Gualtierotti, L.P. Solimeno, F. Peyvandi, A. Giachi, S. Arcudi, A. Ciavarella, S.M. Siboni
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis
2024 S. Arcudi, R. Gualtierotti, E. Scalambrino, M. Clerici, S. Hassan, V. Begnozzi, E.A. Boccalandro, C. Novembrino, C. Valsecchi, R. Palla, F. Peyvandi
Rare bleeding disorders: Advances in management
2024 A. Casini, H. Al‐samkari, C. Hayward, F. Peyvandi